Christine Lindenboom
Chief Corporate Communications Officer
Replay available
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2025 Earnings Call
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Vaughn Greenstreet
Chief Executive Officer
Tolga Tangular
Chief Commercial Officer
Pushbull Garg
Chief Medical Officer
Jeff Fulton
Chief Financial Officer
Kazeen Ahmed
Analyst, Bank of America
Gina Wang
Analyst, Barclays
Teresa Vitale
Analyst, Scotiabank Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Alnylam Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.495 Thursday, May 1st, 2025. I would now like to turn the conference over to El Nilem. 00:00:04.495 -- 00:00:06.797 Please go ahead. 00:00:06.797 -- 00:00:10.121 Good morning. I'm Christine Lindenboom, Chief Corporate Communications Officer at El 00:00:10.121 -- 00:00:14.885 Nilem. With me today are Vaughn Greenstreet, Chief Executive Officer, Tolga Tangular, 00:00:14.885 -- 00:00:19.489 Chief Commercial Officer, Pushbull Garg, Chief Medical Officer, and Jeff Fulton, Chief 00:00:19.489 -- 00:00:23.473 Financial Officer. For those of you participating via conference call, the accompanying 00:00:23.473 -- 00:00:27.757 slides can be accessed by going to the events section of the investors page of our website 00:00:27.757 -- 00:00:29.519 investors.alnylam.com 00:00:29.519 -- 00:00:34.846 slash events. During today's call, as outlined in slide two, Yvonne will offer introductory 00:00:34.846 -- 00:00:38.972 remarks and provide some general context. Tolga will provide an update on our global 00:00:38.972 -- 00:00:43.157 commercial progress, Pushkal will review pipeline updates and clinical progress, and 00:00:43.157 -- 00:00:47.282 Jeff will review our financials and guidance, followed by a summary of our upcoming milestones 00:00:47.282 -- 00:00:48.864 before we open the call to your questions. 00:00:48.864 -- 00:00:53.110 I would like to remind you that this call will contain remarks concerning Alnylam's future 00:00:53.110 -- 00:00:56.859 expectations, plans, and prospects, which constitute forward-looking statements for the 00:00:56.859 -- 00:01:00.403 purposes of the safe proper provision under the Private Securities Litigation Reform 00:01:00.403 -- 00:01:02.186 Act of 1995. 00:01:02.186 -- 00:01:05.770 Actual results may differ materi...